CN1142916C - 多巴胺d1受体兴奋剂化合物 - Google Patents

多巴胺d1受体兴奋剂化合物 Download PDF

Info

Publication number
CN1142916C
CN1142916C CNB00803947XA CN00803947A CN1142916C CN 1142916 C CN1142916 C CN 1142916C CN B00803947X A CNB00803947X A CN B00803947XA CN 00803947 A CN00803947 A CN 00803947A CN 1142916 C CN1142916 C CN 1142916C
Authority
CN
China
Prior art keywords
hydrogen
thiophene
halogen
benzazepines
dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB00803947XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1341102A (zh
Inventor
G���ٶ������
G·蒂尔布洛克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Pharmaceutical Development Ltd
Original Assignee
Shire Pharmaceutical Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Pharmaceutical Development Ltd filed Critical Shire Pharmaceutical Development Ltd
Publication of CN1341102A publication Critical patent/CN1341102A/zh
Application granted granted Critical
Publication of CN1142916C publication Critical patent/CN1142916C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CNB00803947XA 1999-02-17 2000-02-17 多巴胺d1受体兴奋剂化合物 Expired - Fee Related CN1142916C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9903671.7 1999-02-17
GBGB9903671.7A GB9903671D0 (en) 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds

Publications (2)

Publication Number Publication Date
CN1341102A CN1341102A (zh) 2002-03-20
CN1142916C true CN1142916C (zh) 2004-03-24

Family

ID=10847990

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00803947XA Expired - Fee Related CN1142916C (zh) 1999-02-17 2000-02-17 多巴胺d1受体兴奋剂化合物

Country Status (17)

Country Link
EP (1) EP1157009A1 (xx)
JP (1) JP2002537288A (xx)
KR (1) KR20010108228A (xx)
CN (1) CN1142916C (xx)
AU (1) AU767332B2 (xx)
BR (1) BR0008329A (xx)
CA (1) CA2363695A1 (xx)
CZ (1) CZ20012973A3 (xx)
EA (1) EA004745B1 (xx)
GB (1) GB9903671D0 (xx)
HU (1) HUP0200057A3 (xx)
IL (1) IL144810A0 (xx)
MX (1) MXPA01008294A (xx)
NO (1) NO20013978L (xx)
PL (1) PL349838A1 (xx)
WO (1) WO2000049000A1 (xx)
ZA (1) ZA200106478B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102276531A (zh) * 2011-05-30 2011-12-14 扬子江药业集团广州海瑞药业有限公司 一种甲磺酸非诺多泮的制备方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
KR20080044840A (ko) 2005-07-15 2008-05-21 에이엠알 테크놀로지, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기위한 용도
AU2006278514A1 (en) * 2005-08-03 2007-02-15 Mia Levite Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists
CN101684096A (zh) * 2008-09-23 2010-03-31 中国科学院上海药物研究所 一类新型苯并氮杂卓类化合物及其制备方法和用途
CA2916653C (en) 2013-06-27 2017-07-18 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561305A (en) * 1975-07-02 1980-02-20 Smithkline Corp Benzazepine derivatives and pharmeceutical compositions containing them
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
US4861771A (en) * 1989-01-27 1989-08-29 Smithkline Beckman Corporation Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102276531A (zh) * 2011-05-30 2011-12-14 扬子江药业集团广州海瑞药业有限公司 一种甲磺酸非诺多泮的制备方法

Also Published As

Publication number Publication date
AU2563200A (en) 2000-09-04
WO2000049000A1 (en) 2000-08-24
ZA200106478B (en) 2002-02-07
HUP0200057A2 (en) 2002-08-28
NO20013978D0 (no) 2001-08-15
CN1341102A (zh) 2002-03-20
NO20013978L (no) 2001-08-15
BR0008329A (pt) 2002-01-29
MXPA01008294A (es) 2002-07-02
AU767332B2 (en) 2003-11-06
EP1157009A1 (en) 2001-11-28
KR20010108228A (ko) 2001-12-07
CZ20012973A3 (cs) 2002-01-16
GB9903671D0 (en) 1999-04-14
IL144810A0 (en) 2002-06-30
EA004745B1 (ru) 2004-08-26
HUP0200057A3 (en) 2004-03-29
PL349838A1 (en) 2002-09-23
CA2363695A1 (en) 2000-08-24
EA200100783A1 (ru) 2002-02-28
JP2002537288A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
CN1100055C (zh) 哌嗪和哌啶化合物
EP0281261B1 (en) 3-aminomethyl derivatives of indane, indoline and dihydrobenzofurane and dihydrobenzothiophene
CA2079189C (fr) Nouvelles (benzocycloalkyl) alkylamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0074304B1 (fr) Ethers tricycliques, leur préparation et les compositions pharmaceutiques les contenant
JP2750187B2 (ja) 治療上有効なテトラリン誘導体
CN1142916C (zh) 多巴胺d1受体兴奋剂化合物
KR100193981B1 (ko) 신규한 8-치환-2-아미노테트랄린
FR2524467A1 (fr) Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
CA2143252C (fr) Derives de benzodioxane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2699918A1 (fr) Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
CN1125821C (zh) 苯并噻吩衍生物及其相应的用途和组合物
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
EP0747379B1 (fr) Dérivés de l'indole, de l'indazole et du benzisoxazole pour le traitement de la schizophrénie
NZ262098A (en) Phenyl substituted tricyclic benzazepine derivatives
CA2220996A1 (fr) Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1284780C (zh) 对多巴胺d2受体和5－羟色胺重摄取位点有高亲和力的8－{4－[3－(5－氟－1h－吲哚－3－基)丙基]－哌嗪－1－基}－2－甲基－4h－苯并[1,4]噁嗪－3－酮甲磺酸盐
US20080194539A1 (en) Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
KR101675450B1 (ko) 중간체로서 광학 활성 3-아미노-1-프로판올 유도체의 제조방법 및 상기 중간체를 이용한 (s)-둘록세틴의 제조방법
EP1187824B1 (fr) Derives de [(2-substitue-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
KR101071293B1 (ko) 광학 활성 2-설포닐옥시-1-헤테로아릴에탄올 유도체의 제조방법 및 이를 이용한 거울상 이성질체적으로 순수한 헤테로아릴-아미노 알코올의 제조방법
US5109006A (en) Certain pharmaceutically active 6H-imidazo[1,2-a]pyridine-5-ones
WO2003053936A1 (en) Dopamine d1 receptor agonist pro-drug compounds & derivatives
FR2787450A1 (fr) Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1476433A1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SERGE DRUG DEVELOPMENT LTD.

Free format text: FORMER OWNER: CENES LTD.

Effective date: 20030618

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20030618

Address after: England Hampshire

Applicant after: Shire Pharmaceutical Dev. Ltd.

Address before: cambridge

Applicant before: Cenes Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee